Spruce Biosciences Shares Rise After Long-Term MPS IIIB Data and Analyst Coverage Begin
Shares of Spruce Biosciences Inc (NASDAQ:SPRB) climbed 3.2% in after-hours trading Monday after the company disclosed long-term data for its tralesinidase alfa enzyme replacement therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) and received a fresh analyst initiation. The data, presented at the 18th International MPS & Related Lysosomal Di…